Poly Medicure share news and announcements
NSE: POLYMEDBSE: 531768Healthcare Equipment & SuppliesSmall Cap
Last close ₹1,444.00down ₹4.90 (0.34%)BSE ₹1,443.20
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,448.90.
52-week range of traded prices to 23 Oct 2026
₹1,182.00Low, 30 Mar 2026₹2,094.30High, 11 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹14,637 Cr425th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 46.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 4.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 10.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 9.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 86,15649.1% delivered
Poly Medicure share news and announcements
541 announcements, routine notices left out, newest first. Page 5 of 11.
Sep 2023
Aug 2023
7 Aug · Board meeting
Jul 2023
13 Jul · Legal
The exchange asked on 12 Jul 2023
Jun 2023
16 Jun · Legal
The exchange asked on 15 Jun 2023
May 2023
6 May · Analysts
Apr 2023
Mar 2023
2 Mar · Legal
The exchange asked on 1 Mar 2023
Jan 2023
28 Jan · Disclosure
28 Jan · Board meeting
27 Jan · Analysts
Nov 2022
16 Nov · Related Party Transaction
Oct 2022
Sep 2022
14 Sep · Corporate action
3 Sep · Legal
The exchange asked on 2 Sep 2022
Aug 2022
4 Aug · Legal
Exchange has sought clarification from Poly Medicure Limited with respect to announcement dated 04-Aug-2022 informing about Outcome of Board Meeting.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.
Jul 2022
Jun 2022
9 Jun · Related Party Transaction
May 2022
Apr 2022
28 Apr · General updates
Feb 2022
11 Feb · Analysts